Literature DB >> 19225705

Altered adhesion molecules expression on peripheral blood mononuclear cells from patients with systemic sclerosis and clinical correlations.

Heloisa Helena Braga Sawaya1, Romy Beatriz Christmann de Souza, Solange Carrasco, Claudia Goldenstein-Schainberg.   

Abstract

The aim of the study was to evaluate the expressions of adhesion molecules (AM) on peripheral blood mononuclear cells (PBMNC) from systemic sclerosis (SSc) patients. Thirty-one SSc patients (ACR) and 20 normal subjects were selected for the study. PBMNC were analyzed for LFA-1alpha, LFA-1beta, ICAM-3, ICAM-1, and L: -selectin expressions. ICAM-3 expression was decreased while ICAM-1 was increased on SSc PBMNC, compared to controls (p = 0.04 and 0.003, respectively). A positive association was found between LFA-1alpha (r = 0.37, p = 0.03), LFA-1beta (r = 0.38, p = 0.002), ICAM-3 (r = 0.42, p = 0.01), and L-selectin (r = 0.38, p = 0.03) expressions and greater number of immunosuppressive drugs taken by SSc patients. Also, anti-centromeric positive SSc patients had lower expressions of LFA-1alpha, LFA-1beta, ICAM-3, and L-selectin. Lower expression of ICAM-3 and higher expression of ICAM-1 suggest that AMs may be involved in the pathogenesis of scleroderma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225705     DOI: 10.1007/s10067-009-1124-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

1.  Macrophage recognition of ICAM-3 on apoptotic leukocytes.

Authors:  O D Moffatt; A Devitt; E D Bell; D L Simmons; C D Gregory
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma.

Authors:  S Majewski; N Hunzelmann; J P Johnson; C Jung; C Mauch; H W Ziegler-Heitbrock; G Riethmüller; T Krieg
Journal:  J Invest Dermatol       Date:  1991-10       Impact factor: 8.551

4.  Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma.

Authors:  H Ihn; S Sato; M Fujimoto; K Kikuchi; K Takehara
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis.

Authors:  M Gruschwitz; P von den Driesch; I Kellner; O P Hornstein; W Sterry
Journal:  J Am Acad Dermatol       Date:  1992-08       Impact factor: 11.527

6.  Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.

Authors:  H Ihn; M Fujimoto; S Sato; K Kikuchi; A Igarashi; Y Soma; K Takehara
Journal:  J Am Acad Dermatol       Date:  1994-10       Impact factor: 11.527

7.  A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.

Authors:  Ghaith M Mitri; Mary Lucas; Noreen Fertig; Virginia D Steen; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2003-01

8.  Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis.

Authors:  A Ateş; G Kinikli; M Turgay; M Duman
Journal:  Scand J Immunol       Date:  2004-03       Impact factor: 3.487

9.  Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes.

Authors:  A R de Fougerolles; T A Springer
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

10.  Cloning and expression of intercellular adhesion molecule 3 reveals strong homology to other immunoglobulin family counter-receptors for lymphocyte function-associated antigen 1.

Authors:  A R de Fougerolles; L B Klickstein; T A Springer
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  4 in total

1.  Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis.

Authors:  Anagha A Divekar; Dinesh Khanna; Fereidoun Abtin; Paul Maranian; Rajeev Saggar; Rajan Saggar; Daniel E Furst; Ram Raj Singh
Journal:  Clin Immunol       Date:  2011-09-05       Impact factor: 3.969

2.  Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations.

Authors:  Vivek Thakkar; Karen A Patterson; Wendy Stevens; Michelle Wilson; Janet Roddy; Joanne Sahhar; Susanna Proudman; Pravin Hissaria; Mandana Nikpour
Journal:  Clin Rheumatol       Date:  2018-04-23       Impact factor: 2.980

3.  Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis.

Authors:  YaoYao Wang; Ye Shu; YangFan Xiao; Qing Wang; Takuro Kanekura; YaPing Li; JiuCun Wang; Ming Zhao; QianJin Lu; Rong Xiao
Journal:  Clin Epigenetics       Date:  2014-11-11       Impact factor: 6.551

4.  Increased L-Selectin on Monocytes Is Linked to the Autoantibody Profile in Systemic Sclerosis.

Authors:  Neža Brezovec; Katja Perdan-Pirkmajer; Tadeja Kuret; Blaž Burja; Snežna Sodin-Šemrl; Saša Čučnik; Katja Lakota
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.